MAPT and Cognitive impairment: In particular, how tryptophan-derived metabolites affect tau phosphorylation and GSK-3 signaling is not yet fully understood, and whether CKDB001 can modulate cholinergic dysfunction and reshape microbiota–metabolite interactions in a scopolamine-induced model of cognitive impairment remains unclear.